APOL1 Related Kidney Disease: Navigating the Heterogeneity of CKD Populations Through Genetic Testing to Develop Targeted Therapies

Time: 1:30 pm
day: Day 1 Track 2 PM


  • The unmet need: genetics and epidemiology of Apol1 in CKD
  • Identifying the target population: pathophysiology of Apol1 kidney disease
  • Overview of therapies currently in development